Richard H. J. Beǵent

Author

Also Known As

A. J. Green, R BEGENT, R Begent, R H Begent, R H J Begent, R. Begent, R. H J. Begent, R. H. BEGENT, R. H. Begent, R. H. J. BEGENT

227

Publications

9.3K

Citations

H-Index

197

Concepts

All Affiliations

University College London The Royal Free Hospital Charing Cross Hospital Roland Hill (United Kingdom)Cancer Research UK

About

Richard H. J. Beǵent is an author at University College London specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	72	4.4K
2	Engineering	13	13	498
3	Health Sciences	13	14	1.2K
4	Natural Sciences	7	7	289
5	Nursing	1	1	45

Richard H. J. Beǵent

129

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. Mark Bower, E.S. Newlands, L. Holden, Journal of Clinical Oncology	1997	309
Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library Richard H. J. Beǵent, Marlies J. Verhaar, Kerry Chester, Nature Medicine ImmunologyImmunotherapeuticsImmunotherapyTumor ImmunologyTumor Immunity	1996	241
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy D.B. Smith, ES Newlands, Gordon Rustin, The Lancet Antiemetic ProphylaxisMedicinePharmacologyCisplatin-containing ChemotherapyPharmacotherapy	1991	211
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours Nicholas C. Turner, Sandra J. Strauss, Debashis Sarker, British Journal of Cancer	2010	193
Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989 E.S. Newlands, K. D. Bagshawe, Richard H. J. Beǵent, BJOG An International Journal of Obstetrics & Gynaecology	1991	182
Central nervous system metastases of choriocarcinoma. 23 Years' experience at Charing Cross Hospital A. Athanassiou, Richard H. J. Beǵent, E.S. Newlands, Cancer Surgical OncologyBrain MetastasesHigh-grade GliomasCns DiseaseNeuro-oncology	1983	181
Phage libraries for generation of clinically useful antibodies Kerry Chester, Richard H. J. Beǵent, L. Robson, The Lancet Phage LibrariesMedicineBioanalysisImmunologyAntibody Screening	1994	178
Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984) E.S. Newlands, K. D. Bagshawe, Richard H. J. Beǵent, BJOG An International Journal of Obstetrics & Gynaecology	1986	171
A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours Roslyn J. Francis, Sanjay Sharma, Caroline J. Springer, British Journal of Cancer Tumour ResponseOther CeaImmunologyPathologyImmunotherapeutics	2002	162
Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. Gordon Rustin, E.S. Newlands, Richard H. J. Beǵent, Journal of Clinical Oncology Surgical OncologyPathologyPharmacotherapySurgeryMetronomic Chemotherapy	1989	158

Page 1